Medi-Tech Insights

  Increasing demand for workflow optimization in healthcare organizations, increasing regulatory requirements and government initiatives aimed at promoting the adoption of healthcare RCM solutions, rising adoption of cloud-deployed healthcare RCM, growing strategic initiatives associated with healthcare revenue cycle management, and increasing revenue loss due to billing error and declining reimbursement are some of the key factors driving the global Healthcare Revenue Cycle Management market. Healthcare Revenue Cycle Management is the process of identifying, collecting, and managing the practice’s revenue from payers based on the services given. A successful healthcare RCM process is critical for a healthcare practice to maintain financial viability and continue providing quality patient care. Increasing Potential of RCM Outsourcing in Healthcare Drives the Healthcare Revenue Cycle Management Market Leveraging technology provided by outsourcing partnerships can offer various ad...

  Increasing number of clinical trials, a surge in the volume of data generated, and an increase in the number of eTMF system users are some of the key factors driving the eTMF systems market. However, inadequate trained professionals and clinical data privacy are some of the challenges that are likely to hamper the global eTMF Systems Market growth. Electronic Trial Master File (eTMF) is a content management system  for the  Bio-Pharma industry which includes protocols, strategies, and tools used throughout the lifecycle of the clinical trial. An eTMF digitally captures, shares, and stores the essential documents and content generated in a clinical trial. Increasing Adoption due to benefits Offered by eTMF Systems drive the Electronic Trial Master File (eTMF) Systems Post Covid-19 pandemic, the number of clinical trials and volume of data generated increased exponentially, which in turn has fueled the adoption of eTMF systems by Bio-Pharma companies. The eTMF systems g...

Rising need for personalized medicine, continuous advancement in medical technology both for the diagnosis and the treatment of patients, decreased costs of genetic-based CDx tests which allow broader market access, growing cases of adverse drug reactions and side effects, and rising demand for next-generation sequencing are some of the key factors driving the global companion diagnostics market. Companion diagnostic (CDx) is a diagnostic test used as a companion to a therapeutic drug to discover its applicability to a person. It requires multiple monitoring methods to provide extremely valuable data, allowing patients, health practitioners, and payers to decide with a higher level of certainty on the possible advantages of a treatment or care pathway. Growing Demand for NGS-Based Technology Drives the Companion Diagnostics Market The increasing demand for next-generation sequencing technology especially its capability to identify rare variants is crucial to continuing succ...

Global Newborn Screening Market is projected to grow at a CAGR of ~6-8% from 2022 to 2027. This is likely to be driven by an apparent rise in common birth defects, growing lab efficiency, growing populations, and increasing incomes/affluence in SEA and other developing economies.   Newborn screening aims to detect infants at risk of genetic, hormonal and metabolic conditions. These screenings are used to confirm a diagnosis and enable for early intervention in the hope of the prevention or amelioration of the disease. These tests are most commonly performed for conditions that are not clinically evident in the neonatal period but are likely to be treatable with early intervention. Commonly covered conditions include congenital hypothyroidism (CH), Phenylketonuria (PKU), congenital adrenal hyperplasAia (CAH), cystic fibrosis (CF), galactosemia (GAL), tyrosinemia type I (HT1), sickle cell anaemia, G6PD-Deficiency, hearing problems (congenital deafness) and congenital heart probl...